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The usefulness of methanol extract of Curcuma longa in management of benign prostatic 
hyperplasia (BPH) in rats was studied. Twenty male Wistar rats were divided into five 
groups of 4 rats each. BPH was induced by subcutaneous injection of dihydrotestosterone 
(DHT) and estradiol valerate (10:1) daily for 28 days. The normal control (NC) received 
subcutaneous olive oil (as vehicle) for the same duration. The disease control (HC) and 
drug control groups (DC) were given subcutaneous olive oil and oral finasteride 
(standard drug: 5 mg/kg bw) respectively after induction of BPH. Rats in the test groups 
(T1 and T2) were given 100 and 200 mg/kg.bw of C. longa methanol extracts orally for 28 
days respectively, following disease induction. Phytochemical constituents of plant 
extracts, selected biomarkers of BPH, serum electrolyte and hormonal profile were 
determined using standard methods. Results revealed that C. longa have higher content 
of flavonoid (4.03 ± 0.01 mg/100 g) with lower concentration of terpene (0.40 ± 0.07 
mg/100 g). There was significant decrease (p<0.05) in relative prostate weight and 
prostate specific antigen (PSA) in T1 and T2 compared to the HC group. Calcium and 
sodium showed significant (p<0.05) decreased following administration of plant extract 
while chlorine and bicarbonate recorded no (p>0.05) difference. There was a (p<0.05) 
decrease in serum total testosterone and increase in FSH level, but no difference 
(p>0.05) was seen in serum estradiol levels within all experimental groups. This study 
reveals that C. longa may be useful in the treatment and/or management of BPH and its 
complications. 
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The use of complementary traditional medicine 
in the treatment of various diseases has 
expanded rapidly due to their affordability, 
accessibility and efficacy. Benign prostatic 
hyperplasia (BPH) is the most common disease 
of the prostate in aging men resulting from a 
progressive age-related non-cancerous 
enlargement of the epithelial cells and smooth 
muscle of the prostate gland (Paolone, 2010). 
Generally, BPH affects approximately one in four 
men in their 50s, one in three men in their 60s 
and one in two men in their 80s (Kramer et al., 
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2007; Robert et al., 2009). In Nigeria, Ezeanyika 
et al. (2006) reported that one-in-four men 
older than 40 years have symptoms suggestive 
of BPH. The condition often affects individual’s 
quality of life (Ojewola et al., 2017) and may 
progress into bladder dysfunction and eventually 
lead to acute urinary retention if not corrected 
(Roehrborn et al., 2008). 
The etiology underlying the 
development of BPH is multifactorial and not 
well established. Although ageing represents the 
central mechanism implicated, recent findings 
have linked the development of BPH with 
hormonal alterations (Marker et al., 2003), 
metabolic syndrome (Rees and Kirby, 2014), 
nutritional factors (Bravi et al., 2006) and 
inflammation (Kok et al., 2009). However, none 
of these factors is completely understood and 
data on the hormonal profile and serum 
electrolytes in prostate pathologies are 
ambiguous. Dihydrotestosterone (DHT) a 
metabolite of testosterone that is formed by the 
breakdown of testosterone by an enzyme (5α-
reductase) in the prostate cell-has been 
implicated as the main mediator of BPH 
development (Carson and Rittmaster, 2003). 
Recent studies (Altaf et al., 2016; 
Manappallil et al., 2019) have suggested that 
certain treatment methods of BPH or acute 
urinary retention due to BPH can cause serum 
electrolyte disturbances in addition to any 
underlying chronic diseases such as kidney 
failure. Hydro-electrolytic disorders are very 
common in many clinical and surgical situations 
and may be fatal if not corrected. Recently, 
many developing countries worldwide are 
focusing on phytotherapy as an alternative 
medicine for the management of BPH. This 
approach is becoming popular due to the cost 
and unwanted side effects associated with the 
conventional medical treatment options (Traish 
et al., 2011) in addition to the fact that it is 
readily accessible, cheap and do not require 
medical prescription to be acquired. 
Curcuma longa Linn. (turmeric) is a 
member of the ginger family (Zingiberaceae) 
and native to Southwest India. It is a 
rhizomatous herbaceous perennial plant and has 
a very long history of use in various forms of 
folk medicine because of its many health 
benefits. In Nigeria, the plant is traditionally 
used mainly for the relief of gastrointestinal 
disorders, arthritis, inflammation and gastritis 
and also as spices in food. C. longa has been 
reported to possess some potential therapeutic 
characteristics against several chronic diseases 
such as hyperglycemia (Garkuwa et al., 2017), 
inflammation and oxidative stress (Konak and 
Şener, 2019). It has been shown to possess 
antimicrobial activity against food-borne 
pathogenic bacteria (Onwuegbuchu et al., 2021) 
and has been reported to have a 
hepatoprotective characteristic similar to 
Silymarin (Chattopadhyay et al., 2004). These 
properties of C. longa in traditional medicine to 
treat diseases encouraged this research to 
evaluate its usefulness in the management of 
BPH and its potential effects on serum 
electrolytes level in male Wistar albino rats. 
 
MATERIALS AND METHODS 
  
Plant Collection and Preparation: Matured 
fresh C. longa (Tumeric) rhizomes were 
purchased from local daily market at Umudike, 
Abia State, Nigeria. The sample was identified 
(Onwuegbuchu et al., 2021) and authenticated 
by a plant taxonomist in the Department of 
Plant Science and Biotechnology, Michael 
Okpara University of Agriculture, Umudike. 
Voucher specimen number (MOUAU/PSB/BCH/077) 
was kept in the herbarium of the Department 
for referral. The samples were properly washed, 
cut into pieces, shade dried to a constant 
weight and processed into fine powder using a 
laboratory sized electric blender. The resulting 
powder was transferred into an airtight 
container and stored at room temperature until 
use. 100 g of the C. longa powder was 
macerated in a 250 mL of methanol for 48 
hours and filtered with Whatman No. 1 filter 
paper. Then the filtrate was evaporated to 
dryness at 45 oC using water bath to obtain the 
crude extract.  
 
Quantitative Phytochemical Screening: 
Flavonoid, saponin, tannins and alkaloids were 
evaluated according to the methods of Harborne 
(1998), while cardiac glycosides, phenol, 
anthocyanides, terpenes and steroids were 
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determined following the methods of Trease 
and Evans (1989). All chemicals and drugs used 
in the study were of analytical grade.  
 
Experimental Animal: Fourty five (45) male 
albino rats of the Wistar strain weighing 90 – 
130 grams were procured from the Animal 
Breeding Unit of College of Veterinary Medicine, 
Michael Okpara University of Agriculture, 
Umudike (MOUAU). The animals were housed in 
standard transparent cages with wheat husk 
bedding, renewed every 24 hours. They were 
kept under controlled room temperature (25 to 
29 0C) and humidity (50 ± 20%) in a 12 hours 
light-dark cycle. Animals were acclimatized for 
two weeks to laboratory conditions before 
commencing the study.  The animals were given 
standard rat feed (Vital Feed with 18% crude 
protein and 2800 kcal metabolizable energy) 
and had free access to water throughout the 
duration of the study. Ethical approval for the 
study (MOUAU/EC/21/081) was obtained from 
the MOUAU Committee on Animal Use and Care. 
All investigations were conducted in accordance 
with the accepted principles for laboratory 
animal use and care (NRC, 2011).  
 
Acute Toxicity of Curcuma longa: The acute 
toxicity of the C. longa was determined in two 
phases using the methods of Lorke (1983), in 
which the outcome from each stage determines 
the next step. Fourteen mice were used for this 
study. Phase one is divided into three groups of 
two mice per group and were orally 
administered the extract at the doses of 100, 
400 and 1000 mg/kg respectively. The animals 
were observed for at three hours intervals for 
24 hours for behavioral sign of toxicity and 
mortality. Phase two was also made up of three 
groups of two mice per group which were orally 
administered the extract at the doses of 2000, 
3000, and 5000 mg/kg respectively and also 
observed at three hours intervals for 24 hours 
for behavioral sign of toxicity and mortality. A 
confirmatory test was carried out by 
administering 5000 mg/kg to two animals and 
observed for mortality. LD50 was calculated from 
the formula; LD50= (M0 + M1)/2, where M0= 
highest dose that gave no mortality; M1=  
 
highest dose that gave mortality. 
 
Induction of Benign Prostatic Hyperplasia: 
The animals were fasted for 12 to 14 hours with 
free access to water prior to the induction of 
BPH. BPH was induced in rats using a mixture of 
DHT and estradiol valerate (ratio 10:1) following 
the methods of Ejike and Ezeanyika (2011). 
Dose for induction of benign prostatic 
hyperplasia was formulated as 9 mg/kg body 
weight of DHT and 0.9 mg/kg body weight 
estradiol valerate given by subcutaneous 
injection every other day for 28 days. Stock was 
prepared by dissolving 1 g of DHT and 0.1 g 
estradiol valerate in 100 ml of olive oil. The 
induction of BPH was monitored by measuring 
the PSA levels from the blood drawn from the 
tail vein of the test group after 28 days of 
induction and compared with that of negative 
control rats before commencing the oral 
administration.  
 
Experimental Design: A complete randomized 
experimental design comprising of five 
treatment groups replicated thrice with each 
replicate having three rats was used for the 
study. All administration after induction of BPH 
was done orally for duration of 28 days as 
follows: Group I: Normal; received distilled 
water orally and labeled NC. Group II: BPH 
disease control; received olive oil (1 ml/kg) and 
labeled HC. Group III: BPH; received finasteride 
(5 mg/kg; standard drug) and labeled DC. 
Group IV: BPH; received 100 mg/kg.bw of C. 
longa extract and labeled T1 and Group V: BPH; 
received 200 mg/kg.bw of C. longa extract and 
labeled T2. The sublethal dosage used for this 
study was obtain by dividing the LD50 (5000 
mg/kg) by a factor (50) for the initial dose and 
subsequent dose was double. After 28 days, the 
rats starved overnight were anesthetized by a 
brief exposure to trichloromethane vapor. The 
blood was collected by cardiac puncture into a 
sterile plain tube and allowed to clot. Serum 
was separated within an hour of blood clotting 
by centrifugation at 1200 rpm for 5 minutes at 
room temperature to obtain the serum sample 
which was stored frozen at -20 oC until required 
for assay.  
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Relative Prostate Weight: Prostate, liver and 
kidney were excised, washed with normal 
buffered saline, weighed to obtain absolute 
organ weight. The relative organ weights were 
calculated for each rat as the ratio of absolute 
organ weight to final body weight multiplied by 
100. The relative prostrate weight was 
expressed in g/1000 g, while other relative 
organ weights were expressed in g/100g. 
 
Determination of Serum Electrolyte 
Levels: Serum sodium and potassium 
concentrations were determined using flame 
emission photometry method described by 
Margoshes and Vallee (1956). Serum chloride 
concentration was determined using the titration 
method of Schales and Schales (1941) which is 
based on the precipitation of chloride ions in 
serum using mercuric nitrate which reacts with 
diphenylcarbazone to produce a violet color. 
Titration method of Van Slyke and Neil (1924) 
was employed in determining the concentration 
of bicarbonate. The method is based on the 
release of carbon dioxide from bicarbonate ion 
in serum with dilute hydrochloric acid. The 
excess acid was then titrated with sodium 
hydroxide using phenyl red as indicator. 
 
Assay of Hormone Profile and Serum 
Prostate Specific Antigen: Serum samples 
were assayed for estradiol, total testosterone 
(nmol/L) and follicle stimulating hormone (FSH) 
levels using radioimmunoassay (Diagnostic 
Products Corporation, USA) and the level of 
serum PSA was measured by enzyme-linked 
immunosorbant assay (ELISA) kit (BioCheck Inc., 
USA) strictly following manufacturer’s 
instructions. The value was expressed in nano 
grams per ml (ƞg/ml) of serum. 
 
Statistical Analysis: Data obtained were 
statistically analyzed using one-way analysis of 
variance (ANOVA) with Turkey’s multiple 
comparison post hoc tests to compare the level 
of significance between experimental means. 
Probability value of p<0.05 was considered as 
significant. The results were expressed as mean 




Quantitative Phytochemical Constituents 
of Methanol Extract of Curcuma longa: The 
result of the quantitative phytochemical 
evaluation of methanol extract of C. longa is 
shown in Table 1. From the result, the extracts 
of C. longa have high content of flavonoid 
followed by alkaloid and tannin. Terpene and 
phenol had the lowest concentration. 
 
Table 1: Quantitative phytochemical 
composition of methanol extract of 
Curcuma longa 
Parameters Concentration (mg/100 g) 
Alkaloid  2.40 ± 0.07j 
Anthocyanin 1.61 ± 0.01e 
Cardiac glycoside 1.55 ± 0.04d 
Flavonoid 4.03 ± 0.04k 
Phenol  0.51 ± 0.02c 
Saponin 1.87 ± 0.14f 
Steroids 0.33 ± 0.02a 
Tannins  2.22 ± 0.04i 
Terpene 0.40 ± 0.07b 
Values are expressed as mean ± standard error of three 
determinations 
 
Acute Toxicity of Curcuma longa:  C. longa 
extract was not toxic because no mortality and 
behavioral sign of toxicity was recorded at the 
highest dose of 5000 mg/kg except for loss of 
appetite.  
 
Effects of Extract on the Mean Body 
Weight of Animals: The results of mean body 
weight of animals treated with leaf extract of C. 
longa are showed in Table 2. The mean body 
weight of the animals treated with different 
doses of C. longa (T1 and T2) extract had less 
significant gain (p<0.05) in weight after 28 days 
of treatment compared with the NC.  
  
Effect of Curcuma longa Extract Relative 
Organ Weight of Rats: The result for the 
effect of the extract on relative weight of 
prostate, liver and kidney is presented in Table 
3. There was significant change (p<0.05) in 
relative liver, kidney and prostate weight in all 
the groups when compared with that of disease 
group (HC) after the 28-day experimental 
period.  
7
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Table 2: The body weight changes of benign prostatic hyperplasia male rats treated with 

















Initial weight (g) 96.70 ± 1.06a 104.00 ± 1.60b 129.70 ± 3.70d 117.00 ± 1.70c 130.20 ± 1.90d 
Final weight (g) 142.10 ± 4.50b 130.90 ± 5.90a 149.40 ± 4.60d 145.9 ± 3.01c 144.70 ± 3.40c 
% body weight 43.40d 26.00c 19.70b 19.80b 10.00a 
Means on the same row with different letter superscripts are significantly different (p<0.05) 
 
Table 3: Relative organ weights of benign prostatic hyperplasia male rats treated with 
methanol extract of Curcuma longa  
Treatments Absolute organ weight (g) Relative organ weight (g) 
Liver Kidney Prostate Liver Kidney Prostate 
NC 5.24 ± 0.17a 1.27 ± 0.08a 0.10 ± 0.05c 3.69 ± 0.17b 0.89 ± 0.08c 0.07 ± 0.05c 
HC 5.28 ± 0.03c 1.28 ± 0.02b 0.20 ± 0.01d 4.03 ± 0.03c 0.97 ± 0.02c 0.15 ± 0.01d 
DC 5.27 ± 0.03b 1.28 ± 0.01b 0.09 ± 0.02b 3.53 ± 0.03a 0.86 ± 0.01a 0.06 ± 0.02b 
T1 5.28 ± 0.02c 1.28 ± 0.01b 0.09 ± 0.03b 3.62 ± 0.02b 0.88 ± 0.01b 0.06 ± 0.03b 
T2 5.29 ± 0.02d 1.29 ± 0.01c 0.05 ± 0.06a 3.66 ± 0.02b 0.89 ± 0.01c 0.03 ± 0.06a 
NC = Normal control, HC = Disease control, DC = Drug control, T1= 100 mg/kg bw, T2= 200 mg/kg bw, means on the same 
row with different letter superscripts are significantly different (p<0.05) 
 
Table 4: Serum electrolytes concentrations of benign prostatic hyperplasia male rats 
treated with methanol extract of Curcuma longa 
Treatments Sodium (Na) Bicarbonate Chlorine (CL) Calcium (Ca2+) 
NC 127.23 ± 2.31a 26.85 ± 1.29 96.75 ± 1.50c 9.18 ± 0.36c 
HC 169.10 ± 2.15c 27.25 ± 1.26 96.25 ± 1.50c 13.01 ± 0.21d 
DC 197.30 ± 17.83d 27.00 ± 1.15 95.25 ± 1.50b 8.36 ± 0.15b 
T1 157.88 ± 2.54b 27.13 ± 0.48 94.50 ± 1.50a 6.93 ± 0.60a 
T2 162.67 ± 1.77c 27.50 ± 0.58 94.00 ± 1.41a 8.71 ± 0.13b 
NC = Normal control, HC = Disease control, DC = Drug control, T1= 100 mg/kg bw, T2= 200 mg/kg bw, means on the same 
row with different letter superscripts are significantly different (p<0.05) 
 
Following the oral administration of methanol 
extract of C. longa, there was significant decrease 
(p<0.05) in relative prostate weights in the 
experimental group (T1andT2) compared to the 
HC. Similar trend was seen in the relative weight 
of liver and kidney. 
 
Effect of Methanol Extract of Curcuma longa 
on Serum Electrolytes: Table 4 showed the 
effect of extract administration on serum 
electrolytes of DHT-estradiol valerate induced BPH 
Wistar albino rats. There was no significant 
differences (p>0.05) in bicarbonate and chloride 
levels in all the variables evaluated when 
compared with the disease control group (HC). 
The result of serum sodium and calcium 
concentration revealed a significant decrease 
(p<0.05) in all experimental groups when 
compared with the disease control groups (HC).   
Effect of Methanol Extract of Curcuma longa 
on Serum PSA and Hormone Profile: There 
was significant decrease (p<0.05) in the serum 
PSA levels (Figure 1) and total serum testosterone 
levels (Figure 2) but significant increase (p<0.05) 
in FSH levels (Figure 3) in the experimental groups 
(T1and T2) when compared with that of the HC. 
But no significant effect (p>0.05) was seen with 





Phytotherapy is increasing becoming important in 
the treatment of numerous diseases due to many 
side effects of surgery, synthetic drugs and long 
latency of benign prostatic hyperplasia (BPH) thus 
phytotherapy based on product derived naturally 
from plant has emerged as an alternative 
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showed high concentration of flavonoids, 
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The result of this study is in agreement with 
Pawar 
(2021) who also reported high content of 
flavonoid and alkaloid in 
Flavonoids, phenol and tannin 
reported to exert multiple biological activities 
including antimicrobial, cytotoxicity, anti
inflammatory as well as antitumor, but the best 
described property of these biological 
compounds is their capacity to act as powerful 
antioxidants
thus
reactive oxygen species actions. The observed 
effects of 
be attributable to the large number of bioactive 
compounds present in the plant.
weight gain showed a reduction in percentage 
body weight gain in disease control rats when 
compared with the NC rats. This result agrees 
with Shin 
in body weight in the presence of BPH. The low 
percentage gain in body weight seen in disease 
group may be attributable to loss of appetite as 
a result of discomfort caused by BPH induction. 
The result also revealed that administration of 
plant extract caused significant reduction in the 
percentage bod
when compared with disease control group 
(HC). The body weight changes serve as a 
sensitive indicator of the general health status 
of animals. This shows that the extract has an 
effect on the overall weight of the animals thus 
suggesting that 
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regulation of body weight gain and obesity (Kim 
et al., 2016).  
In this study the prostate weight 
significantly increased in the disease group 
compared with the NC and the extract treated 
groups. This could be due to growth in the 
quantity of cellular components of the prostate 
tissue (Akbari et al., 2021). When sufficiently 
large, the prostate constricts the urethral canal 
and cause partial or complete obstruction of the 
urethra (Parsons and Kashefi, 2008).  The result 
is also in agreement with Veeresh Babu et al. 
(2010) who reported increase in prostate weight 
as one of the important biomarkers in the 
development of BPH. Thus   many studies have 
tested the inhibitory effects of various 
substances on the development of BPH by 
measuring relative prostate weight. Therefore 
the reduction of prostate weight by methanol 
extract of C. longa may be the reason for its use 
in the management of BPH. 
From the results, variations in different 
electrolyte concentrations were observed among 
the groups. Clinically electrolyte such as sodium, 
chloride and bicarbonate ions are among the 
parameters that are useful in the determination 
of kidney function (Ahmad et al., 2013). A 
significant increase in serum sodium ion was 
observed in HC when compared to the NC. This 
could be attributable to the inability of the 
kidneys to excrete adequate sodium from the 
tubular fluid due to BPH, which led to the 
excess sodium ion levels in the diseased 
animals. The plant extracts reduced sodium 
concentration in treated rats though the effect 
was not significant when compared with the 
untreated group.  
A total calcium levels is often measured 
as part of routine health screening and 
abnormal result is an indicator of an underlying 
problem often associated with kidney disease 
(Kim et al., 2011). The calcium concentration of 
the diseased animal in this study increased 
significantly (p<0.05) when compared with that 
of the NC. However, administration of the plant 
extracts showed a dose-dependent reduction in 
calcium concentration in treated groups. 
Bicarbonate buffer system is the most important 
amongst blood buffers when the pH of the 
blood is considered (Kendrick et al., 2017) thus 
any reduction in serum bicarbonates implies a 
reduction in blood pH. However the result 
showed no significant alteration of bicarbonate 
concentration in all groups indicating that the 
induction of BPH did not alter the pH 
haemostasis. The low serum chloride 
concentration observed in the treated groups 
may be associated with metabolic alkalosis 
which could be due to volume loss from gastric 
content as gastric fluid is rich in chloride (CL-). 
The result of this study is in line with previous 
study reported by Garkuwa et al. (2021). 
Prostate specific antigen (PSA) is 
produced in the prostate and it is normally 
present in small quantities in the serum (Lilja, 
2003). However, its level is elevated under the 
condition of BPH and prostate cancer. Thus a 
decrease in PSA is associated with reduction in 
BPH due to inhibition of 5-alpha reductase, the 
enzyme that catalyze the conversion of 
endogenous testosterone to hydrotestosterone 
which is one of the underlying cause of BPH 
(Iweala and Ogidigo, 2015).  From the result, 
the PSA level in disease control was found to be 
significantly higher than that of the NC. This is 
in agreement with report of Wilt and N’Dow 
(2008) who reported an increase in PSA due to 
BPH. Several medicinal plants and products 
have been reported to possess 5-alpha 
reductase inhibitory activity and attenuate the 
development of BPH. In this study, the 
methanolic extract of C. longa caused great 
reduction in the PSA level indicating that it has a 
positive effect in the management of BPH.  
From the result, there was a significant 
increase in testosterone in disease group when 
compared to the NC group and the extract 
treated groups. The increase in testosterone 
level in BPH rats seen in this study agrees with 
the reports of Stege and Carlstrom (1992), 
however, the result of this study is not in 
agreement with Weisser and Krieg (1997) that 
observed  reduction serum testosterone levels in 
BPH animals, while Suzuki et al. (1995) revealed 
no relationship between testosterone levels and 
the prostate dimensions. Therefore the 
reduction in testosterone level in the groups 
treated with the extracts at the concentrations 
used in this study is an indicator of the potential 
effect of C. longa in the management of BPH 
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which could be attributed to the presence of 
wide array of phytochemicals present in the 
plant. 
 
Conclusion: C. longa methanolic extract has 
shown a great potential in reducing the relative 
weight of prostate, PSA level and improved 
serum electrolyte level that was altered due to 
BPH induction. The study showed that methanol 
extract of C. longa could be useful in the 
management of BPH and the results will 
contribute significantly to the search for locally 
available medicinal plants for the management 
and/or treatment of BPH. Thus it is not 
unreasonable to attribute this effect observed in 
the study the presence of active bioactive 
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